🇺🇸 FDA
Patent

US 9675572

Intravenous omega-3 fatty acid compositions and method of use

granted A61KA61K31/201A61K31/202

Quick answer

US patent 9675572 (Intravenous omega-3 fatty acid compositions and method of use) held by The United States of America as represented by the Secretary of the Army expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/201, A61K31/202, A61K47/14, A61K9/0019